Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: aTyr Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
aTyr Pharma Inc. May 22, 202494.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 2026 | Scribe Therapeutics Inc. | Open-market purchase | +3,000 | $15.00 | $45,000 |
| Sep 22, 2025 | Jasper Therapeutics Inc. | Open-market purchase | +20,000 | $2.43 | $48,600 |
| Apr 26, 2023 | aTyr Pharma Inc. | Option exercise | +6,000 | — | — |
Questions about Svetlana Lucas
What boards is Svetlana Lucas on?
Svetlana Lucas sits on the boards of Jasper Therapeutics Inc. and aTyr Pharma Inc.
How long has Svetlana Lucas served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.